- Home
- AQST vs EAF Comparison
AQST vs EAF Comparison
Compare AQST & EAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AQST | EAF |
|---|---|---|
| Founded | 2004 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 504.0M | 429.4M |
| IPO Year | 2007 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AQST | EAF |
|---|---|---|
| Price | $4.19 | $8.15 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 5 |
| Target Price | $9.00 | ★ $11.75 |
| AVG Volume (30 Days) | ★ 1.0M | 211.0K |
| Earning Date | 05-01-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $67,430,000.00 | ★ $504,134,000.00 |
| Revenue This Year | $10.08 | $4.25 |
| Revenue Next Year | $49.60 | $12.49 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $2.22 | $0.57 |
| 52 Week High | $7.55 | $20.32 |
Technical Indicators
Market Signals| Indicator | AQST | EAF |
|---|---|---|
| Relative Strength Index (RSI) | 53.36 | 52.04 |
| Support Level | $3.70 | $7.65 |
| Resistance Level | $4.35 | $9.78 |
| Average True Range (ATR) | 0.15 | 0.74 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 44.44 | 56.40 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About EAF GrafTech International Ltd.
GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. The company has only reportable segment, Industrial Materials, is comprised of its two product categories: graphite electrodes and petroleum needle coke products. Petroleum needle coke is key raw material used in the production of graphite electrodes.